These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12006143)

  • 1. Enhanced insulin absorption in the rabbit airways and lung by sodium dioctyl sulfosuccinate.
    Dahlbäck M; Eirefelt S; Bäckström K; Larsson P; Almér LO; Wollmer P; Jonson B
    J Aerosol Med; 2002; 15(1):27-36. PubMed ID: 12006143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary clearance of inhaled 99mTc-DTPA: effect of the detergent dioctyl sodium sulfosuccinate in aerosol.
    Evander E; Wollmer P; Jonson B
    Clin Physiol; 1988 Apr; 8(2):105-11. PubMed ID: 2452046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled insulin-intrapulmonary, intranasal, and other routes of administration: mechanisms of action.
    Henkin RI
    Nutrition; 2010 Jan; 26(1):33-9. PubMed ID: 20005465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant dysfunction makes lungs vulnerable to repetitive collapse and reexpansion.
    Taskar V; John J; Evander E; Robertson B; Jonson B
    Am J Respir Crit Care Med; 1997 Jan; 155(1):313-20. PubMed ID: 9001330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer.
    Heinemann L; Klappoth W; Rave K; Hompesch B; Linkeschowa R; Heise T
    Diabetes Care; 2000 Sep; 23(9):1343-7. PubMed ID: 10977030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary study of the efficacy of insulin aerosol delivered by oral inhalation in diabetic patients.
    Laube BL; Georgopoulos A; Adams GK
    JAMA; 1993 Apr; 269(16):2106-9. PubMed ID: 8385716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin inhalation with absorption enhancer at meal-times results in almost normal postprandial insulin profiles.
    Almér LO; Wollmer P; Jonson B; Troedsson Almér A
    Clin Physiol Funct Imaging; 2002 May; 22(3):218-21. PubMed ID: 12076349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose lowering effects of inhaled insulin in healthy cats.
    DeClue AE; Leverenz EF; Wiedmeyer CE; Bryan ME; Reinero CR
    J Feline Med Surg; 2008 Oct; 10(5):519-22. PubMed ID: 18602326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dioctyl sulfosuccinate analysis in near-shore Gulf of Mexico water by direct-injection liquid chromatography-tandem mass spectrometry.
    Mathew J; Schroeder DL; Zintek LB; Schupp CR; Kosempa MG; Zachary AM; Schupp GC; Wesolowski DJ
    J Chromatogr A; 2012 Mar; 1231():46-51. PubMed ID: 22365569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of dioctyl sulfosuccinate (DOSS) towards hydrolysis and photodegradation under simulated solar conditions.
    Batchu SR; Ramirez CE; Gardinali PR
    Sci Total Environ; 2014 May; 481():260-5. PubMed ID: 24602910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of particle size and aerosolization time on the metabolic effect of an inhaled insulin aerosol.
    Kapitza C; Heise T; Fishman RS; Shapiro DA; Gopalakrishnan V; Rave K; Bott S; Perera AD; Heinemann L
    Diabetes Technol Ther; 2004 Apr; 6(2):119-27. PubMed ID: 15117578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species comparison of drug absorption from the lung after aerosol inhalation or intratracheal injection.
    Schanker LS; Mitchell EW; Brown RA
    Drug Metab Dispos; 1986; 14(1):79-88. PubMed ID: 2868870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients.
    Brunner GA; Balent B; Ellmerer M; Schaupp L; Siebenhofer A; Jendle JH; Okikawa J; Pieber TR
    Diabetologia; 2001 Mar; 44(3):305-8. PubMed ID: 11317660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface active agents as enhancers of alveolar absorption.
    Wollmer P; Bäckström K; Zhao H; Nilsson PG; Jonson B
    Pharm Res; 2000 Jan; 17(1):38-41. PubMed ID: 10714606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to peak insulin level, relative bioavailability, and effect of site of deposition of nebulized insulin in patients with noninsulin-dependent diabetes mellitus.
    Laube BL; Benedict GW; Dobs AS
    J Aerosol Med; 1998; 11(3):153-73. PubMed ID: 10186961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vivo experiment to improve pulmonary absorption of insulin using microbubbles.
    Zhao YZ; Xu YY; Li X; Lu CT; Zhang L; Dai DD; Sun CZ; Lv HF; Li XK; Yang W
    Diabetes Technol Ther; 2011 Oct; 13(10):1013-21. PubMed ID: 21745138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchopulmonary absorption of aerosolised insulin.
    Chakraborti RN
    J Indian Med Assoc; 1999 Dec; 97(12):493-5. PubMed ID: 10638125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary insulin administration using the AERx system: physiological and physicochemical factors influencing insulin effectiveness in healthy fasting subjects.
    Farr SJ; McElduff A; Mather LE; Okikawa J; Ward ME; Gonda I; Licko V; Rubsamen RM
    Diabetes Technol Ther; 2000; 2(2):185-97. PubMed ID: 11469258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-action profile of inhaled insulin.
    Heinemann L; Traut T; Heise T
    Diabet Med; 1997 Jan; 14(1):63-72. PubMed ID: 9017356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved oil spill dispersant monitoring in seawater using dual tracers: Dioctyl and monoctyl sulfosuccinates sourced from corexit EC9500A.
    Brunswick P; MacInnis CY; Kim M; Yan J; Fieldhouse B; Brown CE; van Aggelen G; Shang D
    J Chromatogr A; 2019 Aug; 1598():113-121. PubMed ID: 30987784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.